ICOSAVAX, INC. Retained Earnings
ICOSAVAX, INC. had Retained Earnings of -$258.93 million as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2023-11-14
- 2023-09-30: Retained Earnings (Accumulated Deficit) -$258.93M.
- 2023-06-30: Retained Earnings (Accumulated Deficit) -$236.88M.
- 2023-03-31: Retained Earnings (Accumulated Deficit) -$210.39M.
- 2022-12-31: Retained Earnings (Accumulated Deficit) -$185.83M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2023-09-30 | -$258.93M 10-Q · filed 2023-11-14 |
| 2023-06-30 | -$236.88M 10-Q · filed 2023-08-14 |
| 2023-03-31 | -$210.39M 10-Q · filed 2023-05-10 |
| 2022-12-31 | -$185.83M 10-Q · filed 2023-11-14 |
| 2022-09-30 | -$162.21M 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$140.24M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$117.60M 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$94.07M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$75.89M 10-Q · filed 2021-11-15 |
| 2021-06-30 | -$41.50M 10-Q · filed 2021-09-13 |
| 2020-12-31 | -$27.10M 10-K · filed 2022-03-30 |